Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpa Laboratories has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Alpa Laboratories's Cash Ratio or its related term are showing as below:
NSE:ALPA'
s Cash Ratio Range Over the Past 10 Years
Min: 0.77 Med: 2.41 Max: 3.46
Current: 2.68
During the past 13 years, Alpa Laboratories's highest Cash Ratio was 3.46. The lowest was 0.77. And the median was 2.41.
NSE:ALPA's Cash Ratio is ranked better than 84.25% of 965
companies
in the Drug Manufacturers industry
Industry Median: 0.58
vs NSE:ALPA: 2.68
Alpa Laboratories (NSE:ALPA) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Alpa Laboratories Cash Ratio Related Terms
Alpa Laboratories Cash Ratio Historical Data
* Premium members only.
The historical data trend for Alpa Laboratories's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpa Laboratories Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Alpa Laboratories's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpa Laboratories (NSE:ALPA) has a Cash Ratio of 0.00 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Alpa Laboratories and its competitors. Over the past decade, Alpa Laboratories' Cash Ratio has ranged from 0.77 to 3.46. According to the industry distribution chart, Alpa Laboratories ranks #152 out of 965 companies in the Drug Manufacturers industry, placing it in the top 15.8%.
Is Alpa Laboratories' Cash Ratio too high?
Alpa Laboratories' current Cash Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 3.46. Based on the distribution chart, Alpa Laboratories ranks #152 out of 965 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Alpa Laboratories has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Cash Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Alpa Laboratories ranks #152 out of 965 companies for Cash Ratio. This places Alpa Laboratories in the top 16% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.58. Historically, Alpa Laboratories' own Cash Ratio has ranged from 0.77 to 3.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.58, based on 965 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Alpa Laboratories and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpa Laboratories's current Cash Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹95.07, compared to a current price of ₹62.73 — trading 34% below its estimated fair value. The current Cash Ratio is 0.00. Alpa Laboratories' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Cash Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?
Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued.
The current stock price of ₹62.73 is trading 34% below its estimated GF Value™ of ₹95.07.
GuruFocus considers Alpa Laboratories to be Possible Value Trap.
Key valuation signals for NSE:ALPA:
Cash Ratio: 0.00
GF Value™: ₹95.07 vs. price of ₹62.73 (34% below fair value)
No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
75GF Score
Get the complete analysis for NSE:ALPA
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALPA has been successfully added to your 
